Doctors and parents are scrambling after asthma inhaler switch takes popular medication off the market
CNN
Flovent, one of the most commonly prescribed childhood asthma medications, is no longer being manufactured in the United States. GSK, the pharmaceutical company that made it, took if off the shelves January 1 and replaced it with an identical generic version, fluticasone.
Flovent, one of the most commonly prescribed childhood asthma medications, is no longer being manufactured in the United States. GSK, the pharmaceutical company that made it, took if off the shelves January 1 and replaced it with an identical generic version, fluticasone. But what seemed to be a straightforward swap has left some doctors, nurses and parents of children with asthma scrambling for medications to care for young patients. Flovent and its generic belong to a class of asthma medications known as controllers. They work by reducing inflammation in the airways of children with asthma that puts them at risk of flaring — having an asthma attack — when exposed to a trigger. For children with severe asthma, the medication is both necessary and lifesaving. Four-year-old Bryce Cohen is one of those children. He was only 8 months old when he was first in the pediatric ICU for trouble breathing. He was hospitalized again two months after that. In the years since, he has been able to stay out of the hospital, due in large part to Flovent. His asthma has flared up only one time: last summer, when his family and doctors attempted to give him a break from the daily inhaler and he caught a cold. Bryce lives in New York City and is a patient at Columbia University Irving Medical Center. His family hasn’t been able to get the new generic version of Flovent in the past month.
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.
Universities that do breakthrough-level studies are scrambling to understand the effects as their funding agencies slash their budgets.
The Fall-Winter season, featuring Calvin Klein and Thom Browne, marks a series of debuts, returns and decisive shake-ups for American designers.
The US National Institutes of Health is lowering the maximum “indirect cost rate” that research institutions can charge the government, the agency said late Friday – a move that scientists said could be devastating for the nation’s position as a research leader.
See all the best fashion from the Barker Hangar in LA, where the stars gathered for the twice-postponed Critics Choice Awards.
A measles outbreak is growing in a rural area of West Texas where vaccination rates are well below the recommended level.
The explosive rise of run clubs has made fashionable clothing and community engagement a key area of focus for brands.
German fashion designer Kasia Kucharska uses 3D-printed latex to reimagine lace. Her fantastical designs were on show at Berlin Fashion Week and have been worn by celebrities including Julia Fox and Chloe Bailey.
Six dairy herds in Nevada have tested positive for a newer strain of the H5N1 bird flu virus that’s been associated with severe infections in humans, according to the Nevada Department of Agriculture.
The United States is seeing a second peak in flu cases this season. After doctor’s office visits for flu dipped early this year, they jumped past the previous season peak at the end of last month, with a 30% test positivity rate — and there are still months to go.
Here is what we know about polio as a disease, its vaccines and the likely number of lives saved through inoculation.
The Australian model’s risqué approach to dressing in public reached new heights on Sunday, with a controversial barely-there look that stoked controversy.
Haute couture week in Paris showcased extraordinary designs and had plenty of celebratory moments.